ELIZABETH BOYTER: Open Payments
NPI 1215123930 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,387 in 56 payments from 15 companies in 2025. Trend: 2023 $200 · 2024 $1,501 · 2025 $1,387
Food & beverage: $1,387
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $664 |
| UCB, Inc. | 2 | $159 |
| Novartis Pharmaceuticals Corporation | 5 | $139 |
| PFIZER INC. | 5 | $123 |
| Eisai Inc. | 1 | $48 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
| Celgene Corporation | 1 | $31 |
| Astellas Pharma US Inc | 1 | $30 |
| LivaNova USA, Inc. | 1 | $28 |
Products named: QULIPTA, Zilbrysq, NURTEC ODT, KESIMPTA, Leqembi, COSENTYX, UBRELVY, Symbravo.
Industry payments across GA — which companies pay providers there.
